logo
LambdaTest Enhances Mobile App Testing with Camera Image Injection on Virtual Mobile Devices

LambdaTest Enhances Mobile App Testing with Camera Image Injection on Virtual Mobile Devices

San Francisco, CA, May 21, 2025 (GLOBE NEWSWIRE) —
LambdaTest
, a unified agentic AI and cloud engineering platform, has announced a major enhancement to its real-time manual testing suite: Camera Image Injection. This tool empowers developers and quality assurance teams to test image capture, QR code scanning, and barcode scanning functionalities across a wide range of real mobile devices.
The Camera Image Injection tool is compatible with over 3,000 real devices, supporting image-based functionalities and in-app image upload workflows. By enabling this feature, teams can ensure their applications perform seamlessly across diverse device ecosystems, enhancing user experience and application reliability.
This capability removes the reliance on physical devices and enables seamless image injection via Application Programming Interfaces (APIs), saving time, costs, and effort. Teams building applications for FinTech, logistics, retail, and AR platforms can now validate complex visual workflows quickly and efficiently by injecting test images like QR codes or ID cards directly into the virtual camera input.
'Ensuring that mobile applications function flawlessly across various devices is crucial in today's diverse mobile landscape,' said Mayank Bhola, Co-Founder and Head of Product at LambdaTest. 'With the Camera Image Injection feature, we are providing developers with the tools to test and validate image-related functionalities in real-world scenarios, leading to more robust and user-friendly applications.'
The Camera Image Injection rollouts demonstrate LambdaTest's continued commitment to providing innovative, reliable, and accessible tools for modern QA workflows. Whether you're building secure banking platforms, immersive AR experiences, or education-focused web apps, LambdaTest is equipping teams with the tools they need to deliver quality faster and smarter.
About LambdaTest
LambdaTest
is an AI-native, omnichannel software quality platform that empowers businesses to accelerate time to market through intelligent, cloud-based test authoring, orchestration, and execution. With over 15,000 customers and 2.3 million+ users across 130+ countries, LambdaTest is the trusted choice for modern software testing.
For more information, please visit,
https://lambdatest.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Better Fintech Stock: SoFi Technologies vs. Robinhood Markets
Better Fintech Stock: SoFi Technologies vs. Robinhood Markets

Yahoo

timean hour ago

  • Yahoo

Better Fintech Stock: SoFi Technologies vs. Robinhood Markets

SoFi Technologies' earnings growth is accelerating as it benefits from its expanding slate of personal finance solutions. Shares of Robinhood Markets have hit a new all-time high thanks to its strong growth outlook and improved financial position. 10 stocks we like better than SoFi Technologies › Digital bank SoFi Technologies (NASDAQ: SOFI) and online brokerage Robinhood Markets (NASDAQ: HOOD) both leverage their innovative platforms to disrupt the traditional financial services sector. Their strong growth rates have translated into impressive returns: Shares of SoFi are up 95% in the past year, while Robinhood stock has climbed by a remarkable 246%. After such large gains, some investors may wonder if they can keep their rallies going. Let's consider which of these fintech leaders is a better buy for your portfolio today. SoFi Technologies has transformed from a student and personal loans specialist into a comprehensive financial services platform. Its digital-first, one-stop shop approach resonates with consumers. Today, it serves 10.9 million members, nearly twice as many as it served just two years ago. In the first quarter -- in what CEO Anthony Noto described as a "tremendous start to 2025" -- SoFi's adjusted net revenue surged 33% year over year while adjusted earnings per share (EPS) climbed 200% to $0.06. The bank's success reflects its ongoing diversification beyond lending products into more fee-based services, as its members are increasingly utilizing more of its banking accounts, credit cards, investing options, and other financial products. SoFi is now positioned for more consistently profitable growth and high-quality cash flows. Management expects the positive trends to continue: It's targeting full-year adjusted EPS of $0.27 to $0.28 -- nearly double the $0.15 result in 2024. This outlook highlights a key advantage of SoFi over Robinhood Markets, which faces greater earnings uncertainty, as its business is still tied to transaction volumes and shifting financial market conditions. Investors who are confident in SoFi's ability to execute its growth strategy and capture more market share from legacy banks have compelling reasons to buy and hold the stock for the long term. As robust as SoFi's operating and financial results have been, Robinhood's recent momentum has been even stronger. In the first quarter, net revenue increased 50% while EPS more than doubled to $0.37 from $0.17 in the prior-year period. The company that redefined retail investing with its pioneering commission-free trading model is capitalizing on its 25.8 million funded accounts, where users are trading more actively and directing more of their total assets to the platform. Much of the growth story stems from the cryptocurrency market boom. Crypto now represents 43% of the platform's total transaction volume and contributes 27% of total revenue. Still, Robinhood Markets is also diversifying its product and service offerings with professional-level trading tools, banking solutions, wealth management options, and the premium Robinhood Gold subscription, all of which are increasing the company's customer wallet share. Wall Street has cheered Robinhood's traction, sending the stock up 94% year-to-date to a high that surpassed the pandemic-era peak it set in 2021. Robinhood aims to replicate its U.S. success as it expands globally. It plans to launch service in the Asia Pacific region, and is bolstering its presence in the digital asset space through its recent acquisition of crypto exchange Bitstamp. Those international ambitions, compared to SoFi's more domestically focused operations, could support greater long-term top- and bottom-line growth, which would help justify the stock's premium valuation. Notably, both Robinhood and Sofi are trading at forward price-to-earnings (P/E) ratios near 50, suggesting the market's optimism about their potential is fairly equal. Investors who take the view that Robinhood is just getting started on its path toward a dominant position in the online brokerage space should consider making the stock a part of a diversified portfolio. Choosing which of these is the better fintech stock to buy now isn't easy. I'm bullish on both and predict each will deliver positive returns over the next year. If I were forced to pick just one to buy, though, I'd give the edge to SoFi Technologies, which appears to offer a compelling buy-the-dip opportunity with shares still down about 27% from their 52-week high. In my view, SoFi stands to benefit more from a resilient macroeconomic backdrop, fueling lending demand and earnings growth in the coming quarters, which would provide catalysts for the stock to rally higher. Meanwhile, Robinhood must contend with the lofty expectations baked into its stock price following its recent surge. The market's hopes for it could prove difficult to meet, potentially setting the stage for renewed stock price volatility ahead. Before you buy stock in SoFi Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and SoFi Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Dan Victor has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Better Fintech Stock: SoFi Technologies vs. Robinhood Markets was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Echofree Daily Wellness Supplement Launches Nationwide: Simplicity-Focused Option for Auditory Wellness Introduced
Echofree Daily Wellness Supplement Launches Nationwide: Simplicity-Focused Option for Auditory Wellness Introduced

Business Upturn

timean hour ago

  • Business Upturn

Echofree Daily Wellness Supplement Launches Nationwide: Simplicity-Focused Option for Auditory Wellness Introduced

Denver, June 07, 2025 (GLOBE NEWSWIRE) — A new daily wellness supplement called Echofree has officially launched across the United States, offering adults a convenient option to support their general auditory well-being through a plant-based routine. According to the company, Echofree is designed for individuals looking to take a proactive approach to auditory health as part of their everyday lifestyle. Formulated with a blend of naturally derived ingredients, the supplement aims to complement healthy habits and routines that support overall ear wellness. Unlike traditional methods that may involve hardware or advanced interventions, Echofree emphasizes ease of use with its once-daily format. The product's simplicity is a key aspect of its appeal, allowing users to incorporate it into existing wellness regimens without disruption. The company notes that Echofree may be of interest to individuals looking for natural lifestyle support in the context of environmental noise exposure, aging-related wellness needs, or general interest in ear health. Produced in U.S.-based facilities that follow current industry safety standards, the supplement reflects a growing market trend focused on transparency and user education. To help foster consumer trust, Echofree offers detailed labeling, educational resources, and a satisfaction guarantee. More information—including a full list of ingredients and ordering options—is available through the official website at: About EchoFree EchoFree is a U.S.-based wellness brand committed to supporting individuals with easy-to-use, lifestyle-friendly dietary supplements. The company emphasizes transparency, simplicity, and consumer education, with a focus on plant-based formulas produced in facilities that meet current industry manufacturing standards. Media Contact: Company: EchoFree Address: 19655 E 35th Dr #100, Aurora, CO 80011 Email: [email protected] Order Phone Support: (888) 540-0856 SOURCE: EchoFree Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.

Brain Song Announces Official Website Update Featuring Natural Daily Supplement for Focus and Cognitive Support
Brain Song Announces Official Website Update Featuring Natural Daily Supplement for Focus and Cognitive Support

Business Upturn

timean hour ago

  • Business Upturn

Brain Song Announces Official Website Update Featuring Natural Daily Supplement for Focus and Cognitive Support

Wilmington, June 07, 2025 (GLOBE NEWSWIRE) — Brain Song, a digital wellness experience by Binaural Technologies, has updated its official website to showcase a breakthrough audio supplement designed to support clarity, focus, and memory in adults. Now available in the U.S., the newly enhanced platform introduces a 7-minute memory soundwave, offering individuals a natural, non-invasive method to optimize mental performance. According to the official product website ( The Brain Song is a daily-use audio program created to work in sync with the body's neural rhythms—helping listeners reduce mental clutter, improve presence, and feel more cognitively aligned. The new soundwave is positioned as a standalone digital ritual that can be accessed via mobile or desktop, without the need for pills, powders, or physical supplements. 'Our goal is to help people clear their minds and reconnect with focus—without ingesting anything,' said a spokesperson for Binaural Technologies. 'This audio experience reflects our vision for accessible, technology-driven wellness that's rooted in neuroscience and simplicity.' Binaural Technologies affirms that The Brain Song is engineered using advanced sound design principles, including entrainment techniques aligned with memory and concentration patterns. The platform aims to support common wellness goals like cognitive sharpness, calm attention, and improved daily rhythm. As noted on the product website, The Brain Song is backed by a satisfaction guarantee for new users. Full access instructions, FAQs, and purchasing details are now available on the updated site. About Brain Song The Brain Song is a digital wellness innovation from Binaural Technologies, a Delaware-based brand specializing in audio solutions for mental clarity and focus. Designed to support natural brainwave alignment and mindfulness, The Brain Song offers a simple, effective tool for adults seeking cognitive support through sound. Product and Contact Information Brand: Binaural Technologies – The Brain Song Website: Email: [email protected] Mailing Address: 2810 North Church Street, Wilmington, DE 19802, USA Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The statements made about this product have not been evaluated by the Food and Drug Administration. Individual results may vary. Consumers should consult a qualified healthcare provider before beginning any new health regimen. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store